Rudrabhishek Enterprises Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 14, 2025, 9:32 pm

Quick Insight

Rudrabhishek Enterprises Ltd's current market capitalization stands at ₹291 Cr., with a P/E ratio of 21.8 and a ROE of 9.87%. The company's ROCE is at 14.6%, indicating efficient capital utilization. However, the low OPM of 8.78% suggests room for improvement in operational efficiency. With promoters holding a significant 68.64% stake and a P/BV of 1.91x, investor confidence seems decent. The company's healthy ICR of 10.05x provides a cushion for meeting financial obligations. Overall, while Rudrabhishek Enterprises shows promise, enhancing operational margins could be a key focus area for sustainable growth and improved shareholder value.

Competitors of Rudrabhishek Enterprises Ltd

All Competitor Stocks of Rudrabhishek Enterprises Ltd

Quarterly Result

Last Updated: August 1, 2025, 1:05 pm

Below is a detailed analysis of the quarterly data for Rudrabhishek Enterprises Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 36.68 Cr.. The value appears strong and on an upward trend. It has increased from 31.91 Cr. (Dec 2024) to 36.68 Cr., marking an increase of 4.77 Cr..
• For Expenses, as of Mar 2025, the value is 33.46 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 24.15 Cr. (Dec 2024) to 33.46 Cr., marking an increase of 9.31 Cr..
• For Operating Profit, as of Mar 2025, the value is 3.22 Cr.. The value appears to be declining and may need further review. It has decreased from 7.76 Cr. (Dec 2024) to 3.22 Cr., marking a decrease of 4.54 Cr..
• For OPM %, as of Mar 2025, the value is 8.78%. The value appears to be declining and may need further review. It has decreased from 24.32% (Dec 2024) to 8.78%, marking a decrease of 15.54%.
• For Other Income, as of Mar 2025, the value is 0.45 Cr.. The value appears strong and on an upward trend. It has increased from 0.32 Cr. (Dec 2024) to 0.45 Cr., marking an increase of 0.13 Cr..
• For Interest, as of Mar 2025, the value is 0.73 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.56 Cr. (Dec 2024) to 0.73 Cr., marking an increase of 0.17 Cr..
• For Depreciation, as of Mar 2025, the value is 0.17 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.45 Cr. (Dec 2024) to 0.17 Cr., marking a decrease of 0.28 Cr..
• For Profit before tax, as of Mar 2025, the value is 2.77 Cr.. The value appears to be declining and may need further review. It has decreased from 7.07 Cr. (Dec 2024) to 2.77 Cr., marking a decrease of 4.30 Cr..
• For Tax %, as of Mar 2025, the value is 37.91%. The value appears to be increasing, which may not be favorable. It has increased from 26.17% (Dec 2024) to 37.91%, marking an increase of 11.74%.
• For Net Profit, as of Mar 2025, the value is 1.73 Cr.. The value appears to be declining and may need further review. It has decreased from 5.23 Cr. (Dec 2024) to 1.73 Cr., marking a decrease of 3.50 Cr..
• For EPS in Rs, as of Mar 2025, the value is 0.95. The value appears to be declining and may need further review. It has decreased from 2.92 (Dec 2024) to 0.95, marking a decrease of 1.97.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 4:17 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 11:26 am

Below is a detailed analysis of the balance sheet data for Rudrabhishek Enterprises Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 18.00 Cr.. The value appears strong and on an upward trend. It has increased from 17.00 Cr. (Mar 2024) to 18.00 Cr., marking an increase of 1.00 Cr..
• For Reserves, as of Mar 2025, the value is 132.00 Cr.. The value appears strong and on an upward trend. It has increased from 106.00 Cr. (Mar 2024) to 132.00 Cr., marking an increase of 26.00 Cr..
• For Borrowings, as of Mar 2025, the value is 16.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 10.00 Cr. (Mar 2024) to 16.00 Cr., marking an increase of 6.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 37.00 Cr.. The value appears to be improving (decreasing). It has decreased from 42.00 Cr. (Mar 2024) to 37.00 Cr., marking a decrease of 5.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 204.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 176.00 Cr. (Mar 2024) to 204.00 Cr., marking an increase of 28.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 10.00 Cr.. The value appears strong and on an upward trend. It has increased from 9.00 Cr. (Mar 2024) to 10.00 Cr., marking an increase of 1.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 2.00 Cr..
• For Other Assets, as of Mar 2025, the value is 192.00 Cr.. The value appears strong and on an upward trend. It has increased from 165.00 Cr. (Mar 2024) to 192.00 Cr., marking an increase of 27.00 Cr..
• For Total Assets, as of Mar 2025, the value is 204.00 Cr.. The value appears strong and on an upward trend. It has increased from 176.00 Cr. (Mar 2024) to 204.00 Cr., marking an increase of 28.00 Cr..

Notably, the Reserves (132.00 Cr.) exceed the Borrowings (16.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Rudrabhishek Enterprises Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 7.69. This value is within the healthy range. It has decreased from 8.10 (Mar 24) to 7.69, marking a decrease of 0.41.
• For Diluted EPS (Rs.), as of Mar 25, the value is 7.69. This value is within the healthy range. It has decreased from 7.85 (Mar 24) to 7.69, marking a decrease of 0.16.
• For Cash EPS (Rs.), as of Mar 25, the value is 8.28. This value is within the healthy range. It has decreased from 8.78 (Mar 24) to 8.28, marking a decrease of 0.50.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 83.06. It has increased from 71.28 (Mar 24) to 83.06, marking an increase of 11.78.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 83.06. It has increased from 71.28 (Mar 24) to 83.06, marking an increase of 11.78.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 59.58. It has increased from 58.00 (Mar 24) to 59.58, marking an increase of 1.58.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 12.95. This value is within the healthy range. It has increased from 12.77 (Mar 24) to 12.95, marking an increase of 0.18.
• For PBIT / Share (Rs.), as of Mar 25, the value is 12.14. This value is within the healthy range. It has increased from 12.09 (Mar 24) to 12.14, marking an increase of 0.05.
• For PBT / Share (Rs.), as of Mar 25, the value is 10.85. This value is within the healthy range. It has decreased from 10.93 (Mar 24) to 10.85, marking a decrease of 0.08.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 7.47. This value is within the healthy range. It has decreased from 8.10 (Mar 24) to 7.47, marking a decrease of 0.63.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 7.47. This value is within the healthy range. It has decreased from 8.10 (Mar 24) to 7.47, marking a decrease of 0.63.
• For PBDIT Margin (%), as of Mar 25, the value is 21.73. This value is within the healthy range. It has decreased from 22.02 (Mar 24) to 21.73, marking a decrease of 0.29.
• For PBIT Margin (%), as of Mar 25, the value is 20.38. This value exceeds the healthy maximum of 20. It has decreased from 20.85 (Mar 24) to 20.38, marking a decrease of 0.47.
• For PBT Margin (%), as of Mar 25, the value is 18.21. This value is within the healthy range. It has decreased from 18.84 (Mar 24) to 18.21, marking a decrease of 0.63.
• For Net Profit Margin (%), as of Mar 25, the value is 12.53. This value exceeds the healthy maximum of 10. It has decreased from 13.97 (Mar 24) to 12.53, marking a decrease of 1.44.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 12.53. This value is within the healthy range. It has decreased from 13.97 (Mar 24) to 12.53, marking a decrease of 1.44.
• For Return on Networth / Equity (%), as of Mar 25, the value is 8.98. This value is below the healthy minimum of 15. It has decreased from 11.36 (Mar 24) to 8.98, marking a decrease of 2.38.
• For Return on Capital Employeed (%), as of Mar 25, the value is 14.45. This value is within the healthy range. It has decreased from 16.73 (Mar 24) to 14.45, marking a decrease of 2.28.
• For Return On Assets (%), as of Mar 25, the value is 6.63. This value is within the healthy range. It has decreased from 7.98 (Mar 24) to 6.63, marking a decrease of 1.35.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.10. This value is within the healthy range. It has increased from 0.07 (Mar 24) to 0.10, marking an increase of 0.03.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.56. It has decreased from 0.60 (Mar 24) to 0.56, marking a decrease of 0.04.
• For Current Ratio (X), as of Mar 25, the value is 3.34. This value exceeds the healthy maximum of 3. It has increased from 2.92 (Mar 24) to 3.34, marking an increase of 0.42.
• For Quick Ratio (X), as of Mar 25, the value is 3.34. This value exceeds the healthy maximum of 2. It has increased from 2.92 (Mar 24) to 3.34, marking an increase of 0.42.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 10.05. This value is within the healthy range. It has decreased from 10.97 (Mar 24) to 10.05, marking a decrease of 0.92.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 6.79. This value is within the healthy range. It has decreased from 7.96 (Mar 24) to 6.79, marking a decrease of 1.17.
• For Enterprise Value (Cr.), as of Mar 25, the value is 299.89. It has decreased from 303.28 (Mar 24) to 299.89, marking a decrease of 3.39.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.78. This value is within the healthy range. It has decreased from 3.02 (Mar 24) to 2.78, marking a decrease of 0.24.
• For EV / EBITDA (X), as of Mar 25, the value is 12.78. This value is within the healthy range. It has decreased from 13.69 (Mar 24) to 12.78, marking a decrease of 0.91.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.67. This value is within the healthy range. It has decreased from 2.97 (Mar 24) to 2.67, marking a decrease of 0.30.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Price / BV (X), as of Mar 25, the value is 1.91. This value is within the healthy range. It has decreased from 2.42 (Mar 24) to 1.91, marking a decrease of 0.51.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.67. This value is within the healthy range. It has decreased from 2.97 (Mar 24) to 2.67, marking a decrease of 0.30.
• For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness